Recursion Pharmaceuticals, Inc. (RXRX)

Recursion Pharmaceuticals Market Cap

Recursion Pharmaceuticals has a market cap or net worth of $2.25 billion as of May 17, 2024. Its market cap has increased by 112.33% in one year.

• Market Cap: 2.25B
• Enterprise Value: 2.00B
• 1-Year Change: 112.33%
• Ranking: #1853
• Category: Mid-Cap
• Stock Price: $9.42

Market Cap Chart

Since the IPO on April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $2.92B to $2.25B, a decrease of -22.90%. That is a compound annual growth rate of -8.08%.

Market Cap History

Date	Market Cap	% Change
May 16, 2024	2.26B	-4.99%
May 15, 2024	2.38B	-0.40%
May 14, 2024	2.39B	6.01%
May 13, 2024	2.25B	10.24%
May 10, 2024	2.04B	-0.46%
May 9, 2024	2.05B	1.87%
May 8, 2024	2.02B	-2.27%
May 7, 2024	2.06B	-1.68%
May 6, 2024	2.10B	1.13%
May 3, 2024	2.07B	0.57%
May 2, 2024	2.06B	5.40%
May 1, 2024	1.96B	6.65%
Apr 30, 2024	1.84B	-4.64%
Apr 29, 2024	1.92B	0.99%
Apr 26, 2024	1.91B	3.57%
Apr 25, 2024	1.84B	-1.26%
Apr 24, 2024	1.86B	3.12%
Apr 23, 2024	1.81B	1.31%
Apr 22, 2024	1.78B	3.40%
Apr 19, 2024	1.72B	-0.67%
Apr 18, 2024	1.74B	-0.94%
Apr 17, 2024	1.75B	-1.32%
Apr 16, 2024	1.78B	-2.82%
Apr 15, 2024	1.83B	-7.37%
Apr 12, 2024	1.97B	-5.72%

View and export this data all the way back to 2021. Sign Up Today.

Related Stocks

Company	Market Cap
Vera Therapeutics	2.28B
Dyne Therapeutics	2.24B
Geron	2.23B
agilon health	2.22B
AMN Healthcare Services	2.21B
Deciphera Pharmaceuticals	2.20B
Arvinas	2.16B
Teladoc Health	2.16B